Summit Therapeutics Ownership | Who Owns Summit Therapeutics?
Summit Therapeutics Ownership Summary
Summit Therapeutics is owned by 10.28% institutional investors, 84.36% insiders, and 5.35% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 3.31% of SMMT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.46% of its assets in Summit Therapeutics shares.
SMMT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Summit Therapeutics | 10.28% | 84.36% | 5.35% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 23.22M | 3.31% | $181.13M |
Vanguard group | 8.82M | 1.26% | $68.78M |
Blackrock | 7.90M | 1.13% | $61.61M |
Fmr | 7.57M | 1.08% | $59.01M |
State street | 4.12M | 0.59% | $32.16M |
Geode capital management | 2.96M | 0.42% | $23.12M |
Price t rowe associates inc /md/ | 2.04M | 0.29% | $15.93M |
Millennium management | 1.94M | 0.28% | $15.15M |
Balyasny asset management | 1.01M | 0.14% | $7.88M |
Northern trust | 960.30K | 0.14% | $7.49M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Baker bros. advisors lp | 23.22M | 2.31% | $181.13M |
Qvt financial lp | 575.71K | 0.42% | $4.49M |
Wealth management partners | 42.00K | 0.16% | $327.60K |
Vance wealth | 39.27K | 0.13% | $306.27K |
Sargent investment group | 72.00K | 0.11% | $561.60K |
China universal asset management | 82.47K | 0.09% | $643.29K |
Sectoral asset management | 25.00K | 0.08% | $195.00K |
Caption management | 499.10K | 0.06% | $3.89M |
Fullcircle wealth | 12.21K | 0.06% | $121.85K |
Hoylecohen | 86.41K | 0.05% | $673.98K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | 23.22M | 2.31% | 23.22M |
Price t rowe associates inc /md/ | 2.04M | 0.00% | 2.01M |
Millennium management | 1.94M | 0.01% | 1.94M |
Vanguard group | 8.82M | 0.00% | 1.55M |
Balyasny asset management | 1.01M | 0.01% | 1.01M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 4.12M | 0.00% | -3.99M |
Blackrock | 7.90M | 0.00% | -1.92M |
Anson funds management lp | - | - | -941.91K |
Steward partners investment advisory | - | - | -606.50K |
Bank of montreal /can/ | - | - | -589.57K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Baker bros. advisors lp | 23.22M | 2.31% | 23.22M | $181.13M |
Millennium management | 1.94M | 0.01% | 1.94M | $15.15M |
Balyasny asset management | 1.01M | 0.01% | 1.01M | $7.88M |
Qvt financial lp | 575.71K | 0.42% | 575.71K | $4.49M |
Caption management | 499.10K | 0.06% | 499.10K | $3.89M |
Sold Out
Holder | Change |
---|---|
Citadel advisors | -5.00 |
Pacer advisors | -944.00 |
National bank of canada /fi/ | -1.60K |
Metropolitan life insurance co/ny | -6.56K |
Quinn opportunity partners | -11.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 131 | 23.58% | 72,166,501 | 45.37% | 10 | 16.02% | 64 | 10.34% | 45 | 73.08% |
Mar 31, 2024 | 106 | 9.28% | 49,642,039 | 54.58% | 8 | 37.82% | 58 | 28.89% | 26 | 36.84% |
Dec 31, 2023 | 97 | 3.19% | 32,113,817 | -0.21% | 4 | 21.63% | 45 | 7.14% | 19 | - |
Sep 30, 2023 | 94 | -7.84% | 32,181,292 | -7.57% | 4 | 5.44% | 42 | -28.81% | 19 | -9.52% |
Jun 30, 2023 | 102 | 3.03% | 34,817,566 | 65.75% | 9 | 29.84% | 59 | -7.81% | 21 | 50.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 3.41M | 0.46% | -14.85K |
Fidelity Select Biotechnology | 3.36M | 0.46% | -324.50K |
Vanguard Small Cap Index | 2.72M | 0.37% | 5.35K |
iShares Russell 2000 ETF | 2.26M | 0.31% | -5.07K |
Vanguard Institutional Extnd Mkt Idx Tr | 2.06M | 0.28% | 109.93K |
Vanguard Small Cap Value Index Inv | 1.84M | 0.25% | -636.00 |
SPDR® S&P Biotech ETF | 1.19M | 0.16% | 13.23K |
Fidelity Small Cap Index | 895.69K | 0.12% | -22.45K |
Fidelity Growth Compy Commingled Pl S | 868.21K | 0.12% | 146.69K |
Fidelity Extended Market Index | 800.37K | 0.11% | 40.49K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 27, 2024 | Zanganeh Mahkam | Chief Executive Officer | Buy | $127.67K |
Mar 27, 2024 | Zanganeh Mahkam | Chief Executive Officer | Buy | $74.20K |
Mar 26, 2024 | Zanganeh Mahkam | Chief Executive Officer | Buy | $112.50K |
Mar 27, 2024 | Zanganeh Mahkam | Chief Executive Officer | Buy | $96.72K |
Mar 26, 2024 | Dhingra Ankur | Chief Financial Officer | Buy | $375.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | 5 | - |
2023 Q4 | 4 | - |
SMMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools